104 related articles for article (PubMed ID: 26142626)
21. Enhanced transdermal lymphatic drug delivery of hyaluronic acid modified transfersomes for tumor metastasis therapy.
Kong M; Hou L; Wang J; Feng C; Liu Y; Cheng X; Chen X
Chem Commun (Camb); 2015 Jan; 51(8):1453-6. PubMed ID: 25493296
[TBL] [Abstract][Full Text] [Related]
22. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.
Bhatia A; Kumar R; Katare OP
J Pharm Pharm Sci; 2004 Jul; 7(2):252-9. PubMed ID: 15367383
[TBL] [Abstract][Full Text] [Related]
23. Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells.
Eliaz RE; Szoka FC
Cancer Res; 2001 Mar; 61(6):2592-601. PubMed ID: 11289136
[TBL] [Abstract][Full Text] [Related]
24. In vitro percutaneous absorption of all-trans retinoic acid applied in free form or encapsulated in stratum corneum lipid liposomes.
Fresno Contreras MJ; Jiménez Soriano MM; Ramírez Diéguez A
Int J Pharm; 2005 Jun; 297(1-2):134-45. PubMed ID: 15907600
[TBL] [Abstract][Full Text] [Related]
25. Characterization of the surfaces generated by liposome binding to the modified dextran matrix of a surface plasmon resonance sensor chip.
Erb EM; Chen X; Allen S; Roberts CJ; Tendler SJ; Davies MC; Forsén S
Anal Biochem; 2000 Apr; 280(1):29-35. PubMed ID: 10805517
[TBL] [Abstract][Full Text] [Related]
26. Phycocyanin liposomes for topical anti-inflammatory activity: in-vitro in-vivo studies.
Manconia M; Pendás J; Ledón N; Moreira T; Sinico C; Saso L; Fadda AM
J Pharm Pharmacol; 2009 Apr; 61(4):423-30. PubMed ID: 19298687
[TBL] [Abstract][Full Text] [Related]
27. Liposome surface charge influence on skin penetration behaviour.
Gillet A; Compère P; Lecomte F; Hubert P; Ducat E; Evrard B; Piel G
Int J Pharm; 2011 Jun; 411(1-2):223-31. PubMed ID: 21458550
[TBL] [Abstract][Full Text] [Related]
28. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.
Dubey V; Mishra D; Dutta T; Nahar M; Saraf DK; Jain NK
J Control Release; 2007 Nov; 123(2):148-54. PubMed ID: 17884226
[TBL] [Abstract][Full Text] [Related]
29. Comparative study of liposomes, transfersomes and ethosomes as carriers for improving topical delivery of celecoxib.
Bragagni M; Mennini N; Maestrelli F; Cirri M; Mura P
Drug Deliv; 2012; 19(7):354-61. PubMed ID: 23043648
[TBL] [Abstract][Full Text] [Related]
30. Liposomes in investigative dermatology.
Yarosh DB
Photodermatol Photoimmunol Photomed; 2001 Oct; 17(5):203-12. PubMed ID: 11555329
[TBL] [Abstract][Full Text] [Related]
31. Effect of liposomes on rheological and syringeability properties of hyaluronic acid hydrogels intended for local injection of drugs.
El Kechai N; Bochot A; Huang N; Nguyen Y; Ferrary E; Agnely F
Int J Pharm; 2015 Jun; 487(1-2):187-96. PubMed ID: 25882015
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms of Penetration Enhancement and Transport Utilizing Skin Keratine Liposomes for the Topical Delivery of Licochalcone A.
Wu W; Wang Z; Wu Y; Wu H; Chen T; Xue Y; Wang Y; Jiang C; Shen C; Liu L; Zhu H; Liu Q
Molecules; 2022 Apr; 27(8):. PubMed ID: 35458701
[TBL] [Abstract][Full Text] [Related]
33. Elastic liposomes mediated transdermal delivery of an anti-hypertensive agent: propranolol hydrochloride.
Mishra D; Garg M; Dubey V; Jain S; Jain NK
J Pharm Sci; 2007 Jan; 96(1):145-55. PubMed ID: 16960826
[TBL] [Abstract][Full Text] [Related]
34. Hyaluronic Acid-Mediated Drug Delivery System Targeting for Inflammatory Skin Diseases: A Mini Review.
How KN; Yap WH; Lim CLH; Goh BH; Lai ZW
Front Pharmacol; 2020; 11():1105. PubMed ID: 32848737
[TBL] [Abstract][Full Text] [Related]
35. Effect of vehicles and enhancers on the topical delivery of cyclosporin A.
Liu H; Li S; Wang Y; Yao H; Zhang Y
Int J Pharm; 2006 Mar; 311(1-2):182-6. PubMed ID: 16439077
[TBL] [Abstract][Full Text] [Related]
36. Liposomes and skin: from drug delivery to model membranes.
El Maghraby GM; Barry BW; Williams AC
Eur J Pharm Sci; 2008 Aug; 34(4-5):203-22. PubMed ID: 18572392
[TBL] [Abstract][Full Text] [Related]
37. Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability.
Padamwar MN; Pokharkar VB
Int J Pharm; 2006 Aug; 320(1-2):37-44. PubMed ID: 16707237
[TBL] [Abstract][Full Text] [Related]
38. Elongated microparticles tuned for targeting hyaluronic acid delivery to specific skin strata.
Yamada M; Dang N; Lin LL; Flewell-Smith R; Jane L Espartero L; Bramono D; Grégoire S; Belt PJ; Prow TW
Int J Cosmet Sci; 2021 Dec; 43(6):738-747. PubMed ID: 34757625
[TBL] [Abstract][Full Text] [Related]
39. Hyaluronic acid-coated liposomes for active targeting of gemcitabine.
Arpicco S; Lerda C; Dalla Pozza E; Costanzo C; Tsapis N; Stella B; Donadelli M; Dando I; Fattal E; Cattel L; Palmieri M
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):373-80. PubMed ID: 23791684
[TBL] [Abstract][Full Text] [Related]
40. Characterization and skin permeation of ketoprofen-loaded vesicular systems.
Uchino T; Lefeber F; Gooris G; Bouwstra J
Eur J Pharm Biopharm; 2014 Feb; 86(2):156-66. PubMed ID: 23500115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
